Abstract A097: Tubulysin ADC payloads: An antimitotic drug class that retains activity in multidrug resistant models
Year: 2019
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: Seagen (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2993450044
